vs
Assertio Holdings, Inc.（ASRT）与First Bancorp, Inc（FNLC）财务数据对比。点击上方公司名可切换其他公司
First Bancorp, Inc的季度营收约是Assertio Holdings, Inc.的1.9倍（$25.8M vs $13.5M），First Bancorp, Inc同比增速更快（17.5% vs -57.9%），过去两年First Bancorp, Inc的营收复合增速更高（18.1% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
ASRT vs FNLC — 直观对比
营收规模更大
FNLC
是对方的1.9倍
$13.5M
营收增速更快
FNLC
高出75.5%
-57.9%
两年增速更快
FNLC
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $25.8M |
| 净利润 | — | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 48.1% |
| 净利率 | — | 39.4% |
| 营收同比 | -57.9% | 17.5% |
| 净利润同比 | — | 39.7% |
| 每股收益（稀释后） | $-4.54 | $0.91 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFNLC
| Q4 25 | $13.5M | $25.8M | ||
| Q3 25 | $49.5M | $24.5M | ||
| Q2 25 | $29.2M | $22.5M | ||
| Q1 25 | $26.5M | $21.8M | ||
| Q4 24 | $32.2M | $22.0M | ||
| Q3 24 | $29.2M | $20.5M | ||
| Q2 24 | $31.1M | $19.2M | ||
| Q1 24 | $32.4M | $18.5M |
净利润ASRTFNLC
| Q4 25 | — | $10.2M | ||
| Q3 25 | $11.4M | $9.1M | ||
| Q2 25 | $-16.4M | $8.1M | ||
| Q1 25 | $-13.5M | $7.1M | ||
| Q4 24 | — | $7.3M | ||
| Q3 24 | $-2.9M | $7.6M | ||
| Q2 24 | $-3.7M | $6.2M | ||
| Q1 24 | $-4.5M | $6.0M |
营业利润率ASRTFNLC
| Q4 25 | -86.7% | 48.1% | ||
| Q3 25 | 23.2% | 45.2% | ||
| Q2 25 | -27.5% | 43.7% | ||
| Q1 25 | -50.0% | 39.3% | ||
| Q4 24 | -41.9% | 39.5% | ||
| Q3 24 | -10.4% | 44.6% | ||
| Q2 24 | -11.6% | 38.8% | ||
| Q1 24 | -13.4% | 39.3% |
净利率ASRTFNLC
| Q4 25 | — | 39.4% | ||
| Q3 25 | 23.1% | 37.0% | ||
| Q2 25 | -56.0% | 35.8% | ||
| Q1 25 | -51.1% | 32.5% | ||
| Q4 24 | — | 33.1% | ||
| Q3 24 | -10.0% | 36.9% | ||
| Q2 24 | -11.8% | 32.1% | ||
| Q1 24 | -13.9% | 32.5% |
每股收益（稀释后）ASRTFNLC
| Q4 25 | $-4.54 | $0.91 | ||
| Q3 25 | $0.11 | $0.81 | ||
| Q2 25 | $-0.17 | $0.72 | ||
| Q1 25 | $-0.14 | $0.63 | ||
| Q4 24 | $-3.28 | $0.66 | ||
| Q3 24 | $-0.03 | $0.68 | ||
| Q2 24 | $-0.04 | $0.55 | ||
| Q1 24 | $-0.05 | $0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | $95.5M |
| 股东权益账面价值 | $94.0M | $283.1M |
| 总资产 | $267.0M | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资ASRTFNLC
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTFNLC
| Q4 25 | — | $95.5M | ||
| Q3 25 | — | $95.5M | ||
| Q2 25 | — | $95.0M | ||
| Q1 25 | — | $70.0M | ||
| Q4 24 | — | $95.0M | ||
| Q3 24 | — | $95.0M | ||
| Q2 24 | — | $70.0M | ||
| Q1 24 | $38.6M | $70.0M |
股东权益ASRTFNLC
| Q4 25 | $94.0M | $283.1M | ||
| Q3 25 | $105.8M | $274.6M | ||
| Q2 25 | $93.3M | $265.5M | ||
| Q1 25 | $108.5M | $259.7M | ||
| Q4 24 | $121.1M | $252.5M | ||
| Q3 24 | $130.5M | $256.8M | ||
| Q2 24 | $132.2M | $244.7M | ||
| Q1 24 | $134.5M | $242.6M |
总资产ASRTFNLC
| Q4 25 | $267.0M | $3.2B | ||
| Q3 25 | $319.8M | $3.2B | ||
| Q2 25 | $273.8M | $3.2B | ||
| Q1 25 | $286.4M | $3.2B | ||
| Q4 24 | $284.7M | $3.2B | ||
| Q3 24 | $276.0M | $3.1B | ||
| Q2 24 | $279.4M | $3.1B | ||
| Q1 24 | $282.0M | $3.0B |
负债/权益比ASRTFNLC
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.36× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.29× | ||
| Q1 24 | 0.29× | 0.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $37.8M |
| 自由现金流经营现金流 - 资本支出 | — | $34.6M |
| 自由现金流率自由现金流/营收 | — | 133.9% |
| 资本支出强度资本支出/营收 | — | 12.5% |
| 现金转化率经营现金流/净利润 | — | 3.72× |
| 过去12个月自由现金流最近4个季度 | — | $55.3M |
8季度趋势，按日历期对齐
经营现金流ASRTFNLC
| Q4 25 | $-30.0M | $37.8M | ||
| Q3 25 | $-4.8M | $12.9M | ||
| Q2 25 | $19.1M | $7.4M | ||
| Q1 25 | $-12.5M | $2.2M | ||
| Q4 24 | $11.5M | $26.0M | ||
| Q3 24 | $-35.0K | $9.8M | ||
| Q2 24 | $7.4M | $6.4M | ||
| Q1 24 | $7.5M | $-1.5M |
自由现金流ASRTFNLC
| Q4 25 | — | $34.6M | ||
| Q3 25 | — | $12.6M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $828.0K | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | — | $9.6M | ||
| Q2 24 | — | $6.3M | ||
| Q1 24 | — | $-1.8M |
自由现金流率ASRTFNLC
| Q4 25 | — | 133.9% | ||
| Q3 25 | — | 51.4% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 111.7% | ||
| Q3 24 | — | 47.0% | ||
| Q2 24 | — | 32.9% | ||
| Q1 24 | — | -9.8% |
资本支出强度ASRTFNLC
| Q4 25 | — | 12.5% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 1.8% |
现金转化率ASRTFNLC
| Q4 25 | — | 3.72× | ||
| Q3 25 | -0.42× | 1.42× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 3.58× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FNLC
暂无分部数据
